Question 1

Who are the insiders buying Xilio Therapeutics, Inc. stock?

Accepted Answer

InsiderAct tracks all open-market purchases of Xilio Therapeutics, Inc. stock by corporate insiders — including officers, directors, and shareholders owning more than 10% — sourced from public SEC Form 4 filings.

Question 2

What does insider buying at a company mean?

Accepted Answer

When a corporate officer, director, or major shareholder purchases their own company's stock on the open market using personal funds, it signals confidence in the company's outlook. This is especially meaningful when multiple insiders buy within the same 7–14 day window (cluster buying) or when the purchase size exceeds $100,000.

Question 3

How do I find cluster buying signals for a company?

Accepted Answer

InsiderAct automatically detects cluster buying — two or more insiders independently purchasing shares within a 14-day window. When a cluster buy signal is active for a company, it appears prominently on the company's InsiderAct page and on the Signals tab.

Question 4

Has Xilio Therapeutics, Inc. had any recent large insider purchases?

Accepted Answer

InsiderAct tracks all open-market purchases of $100,000 or more at Xilio Therapeutics, Inc.. Large insider purchases are flagged as high-conviction signals because they represent meaningful personal capital commitments by executives or directors who have direct visibility into the company's operations and prospects.

Question 5

Where do the insider transactions on this page come from?

Accepted Answer

All transactions shown on InsiderAct company pages are sourced directly from SEC EDGAR Form 4 filings — the mandatory public disclosures that corporate insiders must submit within 2 business days of any stock transaction. InsiderAct ingests these filings in near real time and filters for open-market purchases and sales.

								1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500.	1MStock price change 1 month after insider bought.
2026-04-16	2026-04-15	Blanchard Cheryl R	Director	Award	10,000	$0.00	$0	N/A	N/A
2026-03-30	2026-03-26	Shannon James Samuel	Director	Purchase	5,000	$8.79	$43,950	-3.2%	N/A
2026-01-05	2026-01-02	Frankenfield Christopher James	CFO	Sale	7,030	$0.64	-$4,520	N/A	N/A
2026-01-05	2026-01-02	Brennan Kevin M.	SVP	Sale	1,826	$0.64	-$1,174	N/A	N/A
2026-01-05	2026-01-01	Brennan Kevin M.	SVP	Exercise Conversion	5,000	$0.00	$0	N/A	N/A
2026-01-05	2026-01-01	Russo Rene	CEO	Exercise Conversion	44,250	$0.00	$0	N/A	N/A
2026-01-05	2026-01-01	Luptakova Katarina	CMO	Exercise Conversion	16,625	$0.00	$0	N/A	N/A
2026-01-05	2026-01-01	Frankenfield Christopher James	CFO	Exercise Conversion	19,375	$0.00	$0	N/A	N/A
2026-01-05	2025-12-31	Luptakova Katarina	CMO	Award	451,885	$0.00	$0	N/A	N/A
2026-01-05	2025-12-31	Frankenfield Christopher James	CFO	Award	668,789	$0.00	$0	N/A	N/A

XLO

Insider Activity

Latest Insider Transactions

Want to see more transactions?